Johnson & Johnson and its subsidiaries involved in the Consumer, Pharmaceutical and Medical Devices and Diagnostics Industry. Johnson & Johnson main focus had been on products related to human health and well-being. Products such as baby care, skin care, oral care, wound care and women’s health care fields are part of the Consumer Industry. Products such as anti-infective, antipsychotic, contraceptive, gastrointestinal, hematology are some of the products categorized in the Pharmaceutical. Products categorized in Medical Devices and Diagnostics are used to treat cardiovascular disease, orthopedic and neurological products, blood glucose monitoring and insulin delivery products, general surgery, bio surgical and energy products. Since Johnson & Johnson do a lot of research, some of the risk factors such as protection of intellectual and proprietary information are present. Moreover, there are some other risk factors such as accounting risk, foreign currency risk, and patent risk. Accounting risk can be as simple as a wrongful data entry. Foreign currency is another risk Johnson & Johnson has to face since they operate business around the world. For example, the rise and fall of dollars’ value can either harm or benefit the company. Patent expiration is another big risk that Johnson & Johnson has to face since they own many patents of drugs and medical devices. Losing any of these patent means losing in profits. Johnson & Johnson has many brand name products that are available in the world. For the consumer industry, some of the products brands are Johnson’s Baby line of products, Aveeno, Neutrogena, Lubriderm, and Listerine. From the Pharmaceutical, product brands are Stelara, Zytiga, Simponi, Prezista, Intelence, Levaquin. Some of the major development of Johnson & Johnson is to be able to hold the patents of the drug calls Levaquin. Due to the patent expiration of this product, the competitors were able to develop and sell it on the market. This results for the sales of Levaquin to dropped 94% in 2012 as compared to 2011. In the industry, Johnson & Johnson is one of the top company and competitor in health care and well-being products. The company employed more than 127,600 employees that involved in research and development, manufacture, sales. Johnson & Johnson holds many patents in product such as drugs and medical devices. Because of the nature of the competition around the world and in the U.S, Johnson & Johnson spent a lot of revenue in research and development, sales and marketing. As one of the top company in the health care and well-being industry, Johnson & Johnson produced and manufactured their own products with the purchase of raw materials from vendors. Johnson & Johnson and its subsidiaries operate 146 manufacturing facilities and occupying approximately 21.6 million square feet in the U.S and around the world. Johnson & Johnson’s strength lies in their sales and marketing department. Since Johnson & Johnson has to compete with many competitors in the U.S and throughout the world, Johnson & Johnson had invested